ELAN vs TAK
Elanco Animal Health Incorporated · Takeda Pharmaceutical Company Limited
Relative return (rebased to 100)
Key stats
| Metric | ELAN | TAK |
|---|---|---|
| Price | $24.57 | $20.75 |
| Market Cap | $12.28B | $33.01B |
| P/E | — | — |
| P/B | 1.86 | — |
| P/S | 2.60 | — |
| ROE | -3.5% | — |
| Net Margin | -4.9% | — |
| Gross Margin | 55.0% | — |
| Revenue Growth | 6.2% | — |
| Dividend Yield | — | — |
| EPS | -$0.46 | — |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.